Frank Yocca, Chief Scientific Officer at BioXcel Therapeutics, Inc. (BTAI), sold 29,370 shares at $48.47 ($1.4M) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Open-market sale of $1.4M BTAI by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.47 | 14,370 | $697K | 48.9% |
| 2 | $48.47 | 14,370 | $697K | 48.9% |
| 3 | $49.30 | 630 | $31K | 2.2% |
| Total | $48.49 avg | 29,370 | $1.4M | 100% |
| Filing → |
| BTAI | SELL | 2024-10-03 | $4K | — | Filing → |
| BTAI | SELL | 2024-09-17 | $245 | — | Filing → |
| BTAI | SELL | 2024-06-18 | $476 | — | Filing → |